These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Substitution therapy after surgery for autonomous adenomas.
    Author: Feldkamp J, Scherbaum WA.
    Journal: Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S85-7. PubMed ID: 9867205.
    Abstract:
    A substitution therapy with L-thyroxine subsequent to surgery on the thyroid gland due to autonomous dysfunction depends in particular on the extent of resection. A specific postoperative therapy is not necessary in areas with sufficient iodine supply if the remaining part of the thyroid gland guarantees a euthyroid metabolic state. The radicalness of the intervention is dependent on the existence of an unifocal, multifocal or disseminated autonomy. Surgery due to disseminated autonomy always necessitates a substitutive therapy with thyroid hormones and in most cases surgery due to multifocal autonomies require the same treatment. The therapy is initiated with a dose of 1.5 microg L-thyroxine per kg body weight. Suppression of the TSH level is not necessary. Due to the greater risk of recurrence the L-thyroxine administration should be complemented in areas of iodine deficiency with approximately 100-200 mg iodide. After operations with functionally adequate thyroid remnants (8-10 ml), an exclusive prophylaxis with 200 mg iodide can be implemented. The result of surgery should be sonographically documented three months after the intervention.
    [Abstract] [Full Text] [Related] [New Search]